Vesanoid 10 mg soft capsules Ireland - English - HPRA (Health Products Regulatory Authority)

vesanoid 10 mg soft capsules

cheplapharm arzneimittel gmbh - tretinoin - capsule, soft - 10 milligram(s) - cytostatic-differentiating agent

Anexate 500 micrograms/5ml, solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

anexate 500 micrograms/5ml, solution for injection or infusion

cheplapharm arzneimittel gmbh - flumazenil - solution for injection/infusion - 500 micrograms/5ml - antidotes; flumazenil

Cholestagel European Union - English - EMA (European Medicines Agency)

cholestagel

cheplapharm arzneimittel gmbh - colesevelam (as hydrochloride) - hypercholesterolemia - lipid modifying agents - cholestagel co-administered with a 3-hydroxy-3-methyl-glutaryl-coenzyme-a (hmg-coa)-reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in low-density-lipoprotein-cholesterol (ldl-c) levels in adult patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone.cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total cholesterol and ldl-c in adult patients with primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated.cholestagel can also be used in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia (see section 5.1).

Xenical European Union - English - EMA (European Medicines Agency)

xenical

cheplapharm arzneimittel gmbh - orlistat - obesity - antiobesity preparations, excl. diet products - xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (bmi) greater or equal to 30 kg/m2, or overweight patients (bmi > 28 kg/m2) with associated risk factors.treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy.

Konakion MM Ampoules 10 mg/ml Solution for Injection and Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

konakion mm ampoules 10 mg/ml solution for injection and oral solution

cheplapharm arzneimittel gmbh - phytomenadione - solution for injection - 10 milligram(s)/millilitre - vitamin k; phytomenadione

Konakion MM Paediatric Ampoules 2 mg/ 0.2 ml oral solution or solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

konakion mm paediatric ampoules 2 mg/ 0.2 ml oral solution or solution for injection

cheplapharm arzneimittel gmbh - phytomenadione - solution for injection - 2/0.2 milligram(s)/millilitre - vitamin k; phytomenadione

Fungizone 50 mg Powder for sterile concentrate Ireland - English - HPRA (Health Products Regulatory Authority)

fungizone 50 mg powder for sterile concentrate

cheplapharm arzneimittel gmbh - amphotericin - powder for concentrate for solution for infusion - 50 milligram(s) - antibiotics; amphotericin b

Questran 4g/sachet, Powder for oral suspension Ireland - English - HPRA (Health Products Regulatory Authority)

questran 4g/sachet, powder for oral suspension

cheplapharm arzneimittel gmbh - colestyramine resin - powder for oral suspension - 4 g/sachet - bile acid sequestrants; colestyramine

VEPESID 100 mg capsule, soft Ireland - English - HPRA (Health Products Regulatory Authority)

vepesid 100 mg capsule, soft

cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide

VEPESID 50 mg capsule, soft Ireland - English - HPRA (Health Products Regulatory Authority)

vepesid 50 mg capsule, soft

cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 50 milligram(s) - podophyllotoxin derivatives; etoposide